Ajooni Biotech Limited (NSE:AJOONI)

Ajooni Biotech Revenue

In the fiscal year ending March 31, 2026, Ajooni Biotech had annual revenue of 1.85B INR with 59.48% growth. Ajooni Biotech had revenue of 619.26M in the quarter ending March 31, 2026, with 103.35% growth.

• Revenue: 1.85B
• Revenue Growth: +59.48%
• P/S Ratio: 0.35
• Revenue / Employee: n/a
• Employees: 134
• Market Cap: 642.47M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	1.85B	689.25M	59.48%
Mar 31, 2025	1.16B	356.18M	44.38%
Mar 31, 2024	802.54M	57.66M	7.74%
Mar 31, 2023	744.88M	4.50M	0.61%
Mar 31, 2022	740.38M	229.99M	45.06%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 9, 2026

Data Sources Report a data error